8月13日，云知声盘中上涨5.46%，报77.3港元，成交额5290.3万港元。
消息面上，公司当日发布自研医学影像多模态大模型U2-RadiMed，标志着大模型能力正式延伸至医学影像领域，完善了"通用基座大模型—三医专业大模型—医学影像多模态大模型"的产品体系，进一步巩固公司在医疗人工智能领域的技术布局。此前公司已发布U2-Med三医大模型并在MedBench评测中位列第一，同时上半年预计营收5.3亿至5.8亿元，同比增长31%至43%，大模型智能体业务同比增长超200%，叠加1亿港元回购计划及高管增持，多重利好持续共振支撑估值修复。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.